AR129164A1 - Ácido nucleico aislado que codifica una proteína de fusión basada en fviii-bdd y en un péptido señal heterólogo, y uso de la misma - Google Patents
Ácido nucleico aislado que codifica una proteína de fusión basada en fviii-bdd y en un péptido señal heterólogo, y uso de la mismaInfo
- Publication number
- AR129164A1 AR129164A1 ARP230101023A ARP230101023A AR129164A1 AR 129164 A1 AR129164 A1 AR 129164A1 AR P230101023 A ARP230101023 A AR P230101023A AR P230101023 A ARP230101023 A AR P230101023A AR 129164 A1 AR129164 A1 AR 129164A1
- Authority
- AR
- Argentina
- Prior art keywords
- fviii
- bdd
- fusion protein
- signal peptide
- heterologous signal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2022111695A RU2818229C2 (ru) | 2022-04-28 | Выделенная нуклеиновая кислота, которая кодирует слитый белок на основе FVIII-BDD и гетерологичного сигнального пептида, и ее применение |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR129164A1 true AR129164A1 (es) | 2024-07-24 |
Family
ID=88519415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230101023A AR129164A1 (es) | 2022-04-28 | 2023-04-27 | Ácido nucleico aislado que codifica una proteína de fusión basada en fviii-bdd y en un péptido señal heterólogo, y uso de la misma |
Country Status (19)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120365434A (zh) * | 2024-01-23 | 2025-07-25 | 上海苹谱医疗科技有限公司 | 一种提高凝血因子ⅷ分泌水平的双信号肽及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4382170A3 (en) * | 2009-12-06 | 2024-09-04 | Bioverativ Therapeutics Inc. | Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
| EP2989208A4 (en) * | 2013-04-22 | 2016-12-07 | Catalent Pharma Solutions Llc | DECORINAL COMPOSITIONS FOR VETERINARY MEDICINE AND USE THEREOF |
| RU2647769C2 (ru) * | 2015-12-30 | 2018-03-19 | Закрытое Акционерное Общество "Биокад" | Химерный улучшенный рекомбинантный фактор VIII |
| KR20180118659A (ko) * | 2016-02-01 | 2018-10-31 | 바이오버라티브 테라퓨틱스 인크. | 최적화된 viii 인자 유전자 |
| JP7357771B2 (ja) * | 2019-09-03 | 2023-10-06 | オソン メディカル イノベーション ファウンデーション | タンパク質生産性の向上のための個別バーコーディングシステムを導入したシグナルペプチド超高速選別方法 |
| WO2021084276A2 (en) * | 2019-11-01 | 2021-05-06 | Freeline Therapeutics Limited | Factor viii construct |
-
2023
- 2023-04-18 IL IL316578A patent/IL316578A/en unknown
- 2023-04-18 CA CA3250663A patent/CA3250663A1/en active Pending
- 2023-04-18 JP JP2024563591A patent/JP2025515356A/ja active Pending
- 2023-04-18 PE PE2024002341A patent/PE20251064A1/es unknown
- 2023-04-18 WO PCT/RU2023/050093 patent/WO2023211315A1/en not_active Ceased
- 2023-04-18 CR CR20240525A patent/CR20240525A/es unknown
- 2023-04-18 AU AU2023261711A patent/AU2023261711A1/en active Pending
- 2023-04-18 KR KR1020247039725A patent/KR20250005425A/ko active Pending
- 2023-04-18 MA MA68435A patent/MA68435A1/fr unknown
- 2023-04-18 EP EP23796915.9A patent/EP4514975A1/en active Pending
- 2023-04-19 TW TW112114536A patent/TW202342751A/zh unknown
- 2023-04-26 UY UY0001040243A patent/UY40243A/es unknown
- 2023-04-27 AR ARP230101023A patent/AR129164A1/es unknown
- 2023-04-27 CN CN202310468986.4A patent/CN117402901A/zh active Pending
- 2023-04-27 PY PY202302331055A patent/PY2331055A/es unknown
-
2024
- 2024-10-27 JO JOJO/P/2024/0240A patent/JOP20240240A1/ar unknown
- 2024-10-28 MX MX2024013281A patent/MX2024013281A/es unknown
- 2024-10-28 CL CL2024003295A patent/CL2024003295A1/es unknown
- 2024-10-28 CO CONC2024/0014703A patent/CO2024014703A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20251064A1 (es) | 2025-04-09 |
| PY2331055A (es) | 2023-12-05 |
| IL316578A (en) | 2024-12-01 |
| CR20240525A (es) | 2025-03-05 |
| EP4514975A1 (en) | 2025-03-05 |
| CO2024014703A2 (es) | 2024-12-30 |
| JP2025515356A (ja) | 2025-05-14 |
| TW202342751A (zh) | 2023-11-01 |
| WO2023211315A1 (en) | 2023-11-02 |
| UY40243A (es) | 2023-11-15 |
| CN117402901A (zh) | 2024-01-16 |
| CA3250663A1 (en) | 2023-11-02 |
| AU2023261711A1 (en) | 2024-11-21 |
| JOP20240240A1 (ar) | 2024-10-27 |
| KR20250005425A (ko) | 2025-01-09 |
| MA68435A1 (fr) | 2025-04-30 |
| CL2024003295A1 (es) | 2025-02-21 |
| MX2024013281A (es) | 2024-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Park et al. | TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. | |
| Morley et al. | eIF4G: translation's mystery factor begins to yield its secrets | |
| Hirai et al. | Degradation of transcription factors, c‐Jun and c‐Fos, by calpain | |
| Johnston et al. | Nucleotide sequence of the luxB gene of Vibrio harveyi and the complete amino acid sequence of the beta subunit of bacterial luciferase. | |
| Inada et al. | Conditionally lethal amber mutations in the leader peptidase gene of Escherichia coli | |
| WO2021198706A3 (en) | Coronavirus vaccines | |
| ATE214100T1 (de) | Herstellung von rekombinanten proteinen in einem rinderadenovirus-expressionsvektorsystem | |
| Trutnyeva et al. | Mimicking carboxyterminal phosphorylation differentially effects subcellular distribution and cell-to-cell movement of Tobacco mosaic virus movement protein | |
| CO2024014703A2 (es) | Ácido nucleico aislado que codifica una proteína de fusión basada en fviii-bdd y en un péptido señal heterólogo, y uso de la misma | |
| BR112022026248A2 (pt) | Conjugados de citocinas | |
| US20250262333A1 (en) | Construct for Transferring Foreign Substance, and Use Thereof | |
| US11814448B2 (en) | Carrier peptide fragment and use thereof | |
| US20140038902A1 (en) | Method of Treating Metastatic Cancer | |
| CN112480242B (zh) | Spink7蛋白在制备预防和/或治疗溃疡性结肠炎的药物中的应用 | |
| AR016208A1 (es) | Fragmento aislado de acidos nucleicos que codifica toda o una porcion substancial de una proteina de transporte de sacarosa, gen quimerico, celula huespedtransformada, polipeptido de dicha proteina, metodo para alterar el nivel de expresion de dicha proteina en una celula huesped, metodo para obtene | |
| Lupski et al. | DNA→ DNA, and DNA→ RNA→ protein: Orchestration by a single complex operon | |
| Lopez et al. | Analysis of IncF plasmids evolution: nucleotide sequence of an IncFIII replication region | |
| PE20242117A1 (es) | Acido nucleico optimizado por codones que codifica la proteina del factor de coagulacion ix, y su uso | |
| Oppenheim | Internal inversion used to study regulation of the int gene in bacteriophage λ | |
| CN109776685A (zh) | 融合蛋白hBD2-haFGF1及其制备方法和应用 | |
| CO2024014690A2 (es) | Ácido nucleico de codón optimizado que codifica la proteína del factor viii de coagulación de dominio b suprimido, y uso del mismo | |
| CN120550077A (zh) | 二硫环肽和含有二硫环肽的生物材料在抗肿瘤中的应用 | |
| JP6830651B2 (ja) | ペプチド、ポリヌクレオチド、ベクター、形質転換体、NFκB阻害剤、及びNFκB亢進性疾患の治療剤 | |
| WO2024048050A1 (ja) | キャリアペプチドフラグメント及びその利用 | |
| ES2161130B1 (es) | Dna recombinante derivado del virus de la sharka y vector de expresion de proteinas heterologas basado en dicho dna recombinante. |